Return to homepagePandemic Pact

Corona Immunitas research program of SSPH+ on the spread and impact of Covid pandemic in Switzerland.

  • Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Total publications:0 publications

Grant number: 0142005547

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $1,372,788.62

  • Funder

    State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)

  • Principal Investigator

    Abteilung Übertragbare Krankheiten Sekretariat der

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

With the continuation of the study already ongoing until the end of 2022, important information on seroprevalence in the Swiss population will be investigated. These findings provide an additional basis based on evidence-based scientific data, which will serve to develop strategies and recommendations as the pandemic progresses and in particular in view of a possible wave of infections in autumn 2022. The main objectives of the SSPH+ Corona Immunitas program to determine SARS-CoV-2 immunity and the effects of the pandemic in Switzerland in this phase (5 & 6) are: 1. Determination of seroprevalence in the population as a result of SARS-CoV-2 infection and/or COVID-19 vaccination, 2. Determination of the proportion of the population with a previous SARS-CoV-2 infection (recovered) without vaccination, 3. Determination of the extent and duration of immunity after infection with SARS-CoV-2 ...